Heartflow (NASDAQ:HTFL) Insider Sells $609,623.40 in Stock

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) insider Campbell Rogers sold 12,156 shares of the stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $50.15, for a total value of $609,623.40. Following the sale, the insider directly owned 16,962 shares in the company, valued at $850,644.30. This represents a 41.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Campbell Rogers also recently made the following trade(s):

  • On Thursday, October 22nd, Campbell Rogers sold 12,157 shares of Heartflow stock. The shares were sold at an average price of $55.01, for a total value of $668,756.57.
  • On Tuesday, November 17th, Campbell Rogers sold 12,157 shares of Heartflow stock. The stock was sold at an average price of $46.39, for a total value of $563,963.23.
  • On Tuesday, November 17th, Campbell Rogers sold 24,188 shares of Heartflow stock. The stock was sold at an average price of $46.39, for a total value of $1,122,081.32.
  • On Thursday, October 22nd, Campbell Rogers sold 23,933 shares of Heartflow stock. The stock was sold at an average price of $55.01, for a total value of $1,316,554.33.
  • On Friday, September 18th, Campbell Rogers sold 19,682 shares of Heartflow stock. The shares were sold at an average price of $50.15, for a total value of $987,052.30.

Heartflow Price Performance

NASDAQ:HTFL traded down $1.26 during trading hours on Thursday, reaching $44.63. The company had a trading volume of 1,279,655 shares, compared to its average volume of 1,615,683. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $60.65. The firm has a market cap of $3.92 billion, a PE ratio of -48.51 and a beta of 2.50. The business’s 50 day moving average price is $51.84 and its 200-day moving average price is $35.47.

Heartflow (NASDAQ:HTFL – Get Free Report) last issued its quarterly earnings data on Thursday, November 12th. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.15. The business had revenue of $72.86 million for the quarter. Heartflow had a negative net margin of 33.11% and a negative return on equity of 20.53%. During the same period in the previous year, the business earned ($0.27) EPS. On average, analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Canaccord Genuity Group raised their price target on shares of Heartflow from $56.00 to $69.00 and gave the company a “buy” rating in a research report on Friday, November 13th. Robert W. Baird upped their price objective on shares of Heartflow from $56.00 to $68.00 and gave the stock an “outperform” rating in a research report on Friday, November 13th. Stifel Nicolaus increased their target price on shares of Heartflow from $45.00 to $70.00 and gave the stock a “buy” rating in a research note on Friday, November 13th. UBS Group began coverage on Heartflow in a research report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 target price on the stock. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $64.00 price target (up from $45.00) on shares of Heartflow in a report on Tuesday, October 20th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $60.12.

View Our Latest Stock Report on Heartflow

Institutional Investors Weigh In On Heartflow

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Algert Global LLC purchased a new position in Heartflow during the third quarter valued at $2,960,000. Castleark Management LLC acquired a new stake in shares of Heartflow in the third quarter valued at about $4,713,000. Virtu Financial LLC purchased a new stake in shares of Heartflow during the third quarter worth about $1,028,000. Allworth Financial LP increased its stake in shares of Heartflow by 56.5% during the third quarter. Allworth Financial LP now owns 828 shares of the company’s stock worth $41,000 after purchasing an additional 299 shares in the last quarter. Finally, Entropy Technologies LP raised its position in shares of Heartflow by 7.1% during the 3rd quarter. Entropy Technologies LP now owns 10,156 shares of the company’s stock worth $505,000 after purchasing an additional 672 shares during the last quarter.

Heartflow Company Profile

(Get Free Report)

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.

Featured Stories

Insider Buying and Selling by Quarter for Heartflow (NASDAQ:HTFL)

Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.